S. Alvarez

发表

Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes.

J. Antoine, J. Mandelbaum, J. Belaïsch-Allart, 1998, Human reproduction.

Human embryo cryopreservation, extrinsic and intrinsic parameters of success.

J. Mandelbaum, J. Cohen, A. Junca, 1987, Human reproduction.

Cryopreservation of human embryos and oocytes.

J. Mandelbaum, J. Cohen, A. Junca, 1988, Human reproduction.

Pregnancies after replacement of frozen-thawed embryos in a donation program.

J. Antoine, J. Mandelbaum, D. Cornet, 1988, Fertility and sterility.

Pregnancies following ovum donation in gonadal dysgenesis.

J. Antoine, J. Mandelbaum, D. Cornet, 1990, Human reproduction.

Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison.

J. Antoine, J. Mandelbaum, D. Cornet, 1990, Human reproduction.

Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization.

J. Antoine, J. Mandelbaum, D. Cornet, 1988, Human reproduction.

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

R. Frydman, P. Bouchard, H. Déchaud, 2000, Fertility and sterility.

Assisted reproductive technology and complex chromosomal rearrangements: the limits of ICSI.

J. Siffroi, B. Benzacken, B. Straub, 1997, Molecular human reproduction.

Preliminary data on the efficacy of a new human menopausal gonadotropin (hMG) preparation containing a reduced amount of luteinizing hormone (LH) for superovulation in an in vitro fertilization (IVF) program

J. Antoine, J. Mandelbaum, D. Cornet, 1992, Journal of Assisted Reproduction and Genetics.

Results of IVF in the treatment of polycystic ovary disease.

J. Antoine, J. Mandelbaum, D. Cornet, 1988, Human reproduction.

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg.

R. Fanchin, R. Frydman, P. Bouchard, 1998, Human reproduction.

Granulosa cells improve human embryo development in vitro.

J. Antoine, J. Mandelbaum, A. Junca, 1993, Human reproduction.

O-093 Plasmatic and follicular fluid levels of a new GnRH antagonist (Cetrorelix) used in IVF patients with a simple single administration protocol in the late follicular phase in stimulated and spontaneous cycles

R. Fanchin, R. Frydman, P. Bouchard, 1997 .

The Implantation Window in Humans after Fresh or Frozen-Thawed Embryo Transfers

J. Mandelbaum, D. Cornet, A. Junca, 1990 .

A case of triple monoamniotic pregnancy combined with a bioamniotic twinning after in-vitro fertilization.

J. Antoine, S. Alvarez, J. Salat-Baroux, 1994, Human reproduction.

Treatment of hyperstimulation during in-vitro fertilization.

J. Antoine, J. Mandelbaum, D. Cornet, 1990, Human reproduction.

Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.

J. Antoine, M. Debray, D. Cornet, 1991, Human reproduction.

Ultrasonographic Prediction of Ovarian Hyperstimulatton (OHS) After IVF

J. Antoine, D. Cornet, S. Alvarez, 1990 .

A function test to assess the responsibility of oocyte and sperm quality in in vitro fertilization failure

J. Mandelbaum, A. Junca, M. Plachot, 1993, Journal of Assisted Reproduction and Genetics.